Literature DB >> 7523634

Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis.

J Strugar1, D Rothbart, W Harrington, G R Criscuolo.   

Abstract

Metastatic brain tumors are almost always associated with vasogenic brain edema, which in turn plays a pivotal role in the evolution of neurological morbidity associated with these lesions. Attention has recently focused on a group of proteinaceous vascular permeability factors (VPF's) that are capable of inducing angiogenesis and promoting increased capillary permeability. To test the hypothesis that metastatic brain tumors expressing VPF's are associated with peritumoral cerebral edema, a rabbit polyclonal immunoglobulin (Ig) G anti-VPF was used to immunostain pathological specimens of metastatic cerebral tumors obtained from 22 patients who underwent surgery at Yale-New Haven Hospital. Magnetic resonance (MR) imaging was used to correlate VPF staining in tumor tissue with the occurrence of peritumoral brain edema. A histological study of the microvasculature was then conducted by immunostaining the specimens for endothelial cell factor VIII surface antigen, using two gliosis specimens as controls. Results revealed 21 of 22 tumors stained positively for VPF's; the negative-VPF tumor was a melanoma that exhibited no peritumoral edema. Twenty of 22 tumors had MR imaging-evident vasogenic edema. The presence and intensity of VPF immunostaining of microvascular features were noted and compared. Factor VIII staining demonstrated tumor vascularity to be most abundant in VPF-rich regions of tumor. The authors therefore report a high correlation between the presence of VPF's and the occurrence of peritumoral brain edema associated with cerebral metastases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523634     DOI: 10.3171/jns.1994.81.4.0560

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  39 in total

1.  Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor-associated cysts.

Authors:  J Vaquero; M Zurita; S Oya; S Coca; C Salas
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  DEP induction of ROS in capillary-like endothelial tubes leads to VEGF-A expression.

Authors:  Ming Wei Chao; Iris P Po; Robert J Laumbach; John Koslosky; Keith Cooper; Marion K Gordon
Journal:  Toxicology       Date:  2012-04-07       Impact factor: 4.221

3.  Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Giuseppe M Giannatempo; Teresa Popolizio; Domenico Catapano; Simona Bonavita; Nicola Maggialetti; Michela Tosetti; Ugo Salvolini; Vincenzo A d'Angelo; Giocchino Tedeschi
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

4.  The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

Authors:  Sophia Ran; Khalid A Mohamedali; Troy A Luster; Philip E Thorpe; Michael G Rosenblum
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 5.  Brain metastases: 1995. A brief review.

Authors:  J B Posner
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 6.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 7.  Anti-angiogenic treatment strategies for malignant brain tumors.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 8.  Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review.

Authors:  William T C Yuh; Greg A Christoforidis; Regina Maria Koch; Steffen Sammet; Petra Schmalbrock; Ming Yang; Michael V Knopp
Journal:  Top Magn Reson Imaging       Date:  2006-04

9.  Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging.

Authors:  X Z Chen; X M Yin; L Ai; Q Chen; S W Li; J P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-28       Impact factor: 3.825

Review 10.  Current advances in understanding and managing secondary brain metastasis.

Authors:  Radhika Dasararaju; Amitkumar Mehta
Journal:  CNS Oncol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.